Perry, Stephen J <br/><br/>
Targeting of cyclic AMP degradation to beta 2-adrenergic receptors by beta-arrestins.  [electronic resource] 

 -  Science (New York, N.Y.)  Oct 2002 
 - 834-6 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>1095-9203 
<br/><br/><label>Standard No.: </label>10.1126/science.1074683  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>3',5'-Cyclic-AMP Phosphodiesterases--genetics<br/>Adrenergic beta-Agonists--pharmacology<br/>Animals<br/>Arrestins--genetics<br/>COS Cells<br/>Cell Line<br/>Cell Membrane--metabolism<br/>Cyclic AMP--metabolism<br/>Cyclic AMP-Dependent Protein Kinases--metabolism<br/>Cyclic Nucleotide Phosphodiesterases, Type 4<br/>Cytosol--metabolism<br/>Humans<br/>Isoenzymes--metabolism<br/>Isoproterenol--pharmacology<br/>Mice<br/>Mutation<br/>Precipitin Tests<br/>Rats<br/>Receptors, Adrenergic, beta-2--genetics<br/>Recombinant Fusion Proteins--metabolism<br/>Transfection<br/>beta-Arrestins